drugset / Trial / NCT00455702

Effects of Weekly Dosing of D-cycloserine on Cognitive Function in Individuals With Schizophrenia

NCT00455702

Phase 4 Completed 38 enrolled Massachusetts General Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study aims to assess the effects of single dose and repeated weekly dosing of 50mg d-cycloserine versus placebo on cognitive and memory functioning in schizophrenia patients. The study will also examine the effects of 50mg d-cycloserine on positive symptoms and negative symptoms, as well as assess tolerability and side-effects.

Timeline

Start
2004-07
Primary completion
2007-04
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Cycloserine Small molecule 50 mg Oral

Indications